Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity

The novel human coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has caused a pandemic. There are currently several marketed vaccines and many in clinical trials targeting SARS-CoV-2. Another strategy is to repurpose approved drugs to decrease the burden of the COVID-19 (offi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mignani, Serge, Shi, Xiangyang, Karpus, Andrii, Lentini, Giovanni, Majoral, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466088/
https://www.ncbi.nlm.nih.gov/pubmed/34575589
http://dx.doi.org/10.3390/pharmaceutics13091513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466088/
https://www.ncbi.nlm.nih.gov/pubmed/34575589
http://dx.doi.org/10.3390/pharmaceutics13091513

Ejemplares similares